261 related articles for article (PubMed ID: 32596739)
41. [Infection by Staphylococcus lugdunensis: clinico-microbiologic characterization of 25 cases].
Ros MJ; Ramírez A; Arteaga E; Alberto C; Gil J; Reina J
Enferm Infecc Microbiol Clin; 1999 May; 17(5):223-6. PubMed ID: 10396086
[TBL] [Abstract][Full Text] [Related]
42. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
Hashem AA; Abd El Fadeal NM; Shehata AS
J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
[TBL] [Abstract][Full Text] [Related]
43. Primary lung abscess caused by Staphylococcus lugdunensis.
Chou DW; Lee CT
J Infect Chemother; 2017 Nov; 23(11):791-793. PubMed ID: 28751155
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of penicillin G susceptibility testing methods for Staphylococcus lugdunensis.
Hagstrand Aldman M; Påhlman LI
J Antimicrob Chemother; 2020 May; 75(5):1206-1211. PubMed ID: 32016343
[TBL] [Abstract][Full Text] [Related]
45. Staphylococcus lugdunensis, an aggressive coagulase-negative pathogen not to be underestimated.
Ravaioli S; Selan L; Visai L; Pirini V; Campoccia D; Maso A; Speziale P; Montanaro L; Arciola CR
Int J Artif Organs; 2012 Oct; 35(10):742-53. PubMed ID: 23065884
[TBL] [Abstract][Full Text] [Related]
46. Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.
Jiang JH; Dexter C; Cameron DR; Monk IR; Baines SL; Abbott IJ; Spelman DW; Kostoulias X; Nethercott C; Howden BP; Peleg AY
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617095
[TBL] [Abstract][Full Text] [Related]
47. Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals.
Petinaki E; Spiliopoulou I; Kontos F; Maniati M; Bersos Z; Stakias N; Malamou-Lada H; Koutsia-Carouzou Ch; Maniatis AN
J Antimicrob Chemother; 2004 Jan; 53(1):105-8. PubMed ID: 14657085
[TBL] [Abstract][Full Text] [Related]
48. Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital.
Hitzenbichler F; Simon M; Salzberger B; Hanses F
Infection; 2017 Apr; 45(2):179-186. PubMed ID: 27660064
[TBL] [Abstract][Full Text] [Related]
49. Severe hospital acquired pneumonia and septicemia due TO methicillin resistant Staphylococcus lugdunensis in a newborn in Northwestern Ethiopia.
Tibebu M
Ethiop Med J; 2014 Apr; 52(2):99-101. PubMed ID: 25588292
[TBL] [Abstract][Full Text] [Related]
50. Prosthetic joint infection due to Staphylococcus lugdunensis.
Sampathkumar P; Osmon DR; Cockerill FR
Mayo Clin Proc; 2000 May; 75(5):511-2. PubMed ID: 10807080
[TBL] [Abstract][Full Text] [Related]
51. Staphylococcus lugdunensis: the coagulase-negative staphylococcus you don't want to ignore.
Babu E; Oropello J
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):901-7. PubMed ID: 21973302
[TBL] [Abstract][Full Text] [Related]
52. Coagulase-negative staphylococci causing blood stream infection at an Indian tertiary care hospital: Prevalence, antimicrobial resistance and molecular characterisation.
Singh S; Dhawan B; Kapil A; Kabra SK; Suri A; Sreenivas V; Das BK
Indian J Med Microbiol; 2016; 34(4):500-505. PubMed ID: 27934830
[TBL] [Abstract][Full Text] [Related]
53. Prevalence, identification, and antimicrobial susceptibility of Staphylococcus lugdunensis from various clinical specimens in Korea.
Shin JH; Jung HJ; Lee HR; Kim JH; Kim HR; Lee JN
Jpn J Infect Dis; 2007 Sep; 60(5):312-3. PubMed ID: 17881876
[TBL] [Abstract][Full Text] [Related]
54. Are coagulase-negative staphylococci virulent?
Heilmann C; Ziebuhr W; Becker K
Clin Microbiol Infect; 2019 Sep; 25(9):1071-1080. PubMed ID: 30502487
[TBL] [Abstract][Full Text] [Related]
55. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program.
Marshall SA; Wilke WW; Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 1998 Mar; 30(3):205-14. PubMed ID: 9572028
[TBL] [Abstract][Full Text] [Related]
56. Skin and soft tissue infections caused by Staphylococcus lugdunensis: report of 20 cases.
Arias M; Tena D; Apellániz M; Asensio MP; Caballero P; Hernández C; Tejedor F; Bisquert J
Scand J Infect Dis; 2010 Dec; 42(11-12):879-84. PubMed ID: 20735327
[TBL] [Abstract][Full Text] [Related]
57. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
[TBL] [Abstract][Full Text] [Related]
58. Septic arthritis of native hip joint by Staphylococcus lugdunensis: a case report.
Gaglani B; Dahdouh M; Shah K
Rev Soc Bras Med Trop; 2018; 51(4):554-556. PubMed ID: 30133645
[TBL] [Abstract][Full Text] [Related]
59. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.
Bourgeois I; Pestel-Caron M; Lemeland JF; Pons JL; Caron F
Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684
[TBL] [Abstract][Full Text] [Related]
60. Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India.
Pal N; Sharma B; Sharma R; Vyas L
J Postgrad Med; 2010; 56(3):182-5. PubMed ID: 20739762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
